{Reference Type}: Journal Article
{Title}: Sclerostin deficiency in humans.
{Author}: van Lierop AH;Appelman-Dijkstra NM;Papapoulos SE;
{Journal}: Bone
{Volume}: 96
{Issue}: 0
{Year}: 03 2017
{Factor}: 4.626
{DOI}: 10.1016/j.bone.2016.10.010
{Abstract}: Sclerosteosis and van Buchem disease are two rare bone sclerosing dysplasias caused by genetic defects in the synthesis of sclerostin. In this article we review the demographic, clinical, biochemical, radiological, and histological characteristics of patients with sclerosteosis and van Buchem disease that led to a better understanding of the role of sclerostin in bone metabolism in humans and we discuss the relevance of these findings for the development of new therapeutics for the treatment of patients with osteoporosis.